PharmiWeb.com - Global Pharma News & Resources
11-Jul-2023

Evonik’s Health Care production site in Ham, France, goes carbon neutral

  • First site in Health Care business to achieve carbon neutrality in Scope 1 and 2 emissions
  • Switch to biogas from local supplier
  • Goal of carbon neutrality in Scope 1 and 2 emissions for all Health Care sites by 2030

11 July 2023

Essen, Germany. Evonik’s production site in Ham in northern France has reduced its direct (Scope 1) and indirect (Scope 2) greenhouse gas emissions to zero. This is the first site from the Health Care business at Evonik to go carbon neutral and underscores the business’s commitment to its goal of becoming carbon neutral in Scope 1 and 2 emissions by 2030.

Evonik Health Care is part of the company’s life sciences division, Nutrition & Care. Guided by a vision that puts sustainability at its core, the division has defined concrete objectives and action plans to achieve carbon neutrality. In the case of the site in Ham, the next phase includes measures and activities to significantly reduce indirect CO2 emissions from supply chains, such as raw materials (Scope 3).

“With this achievement we have taken an important step in our decarbonisation journey. By reducing our footprint, we are providing our customers with the sustainable products they need, while helping to create a healthier, cleaner future for all,” said Thomas Riermeier, head of Evonik’s Health Care business.

Evonik Rexim SAS in Ham, France has been using green electricity since the beginning of 2022. In May this year, the site switched from using natural gas to biogas (biomethane produced from agricultural waste) supplied by local energy company ENGIE. With this new supplier, the site benefits from the well-developed biogas network in northern France.

Evonik’s Health Care business line is a global innovation hub to the world’s leading pharmaceutical, nutraceutical and medical device companies. The production site in Ham manufactures amino acids and peptides for application in cell culture and parenteral nutrition. Approximately 230 employees work at the site, which has been in operation for more than 70 years.   

Editor Details

Last Updated: 11-Jul-2023